Aytu Biopharma (AYTU) Depreciation & Amortization (CF) (2010 - 2026)
Aytu Biopharma (AYTU) posted quarterly Depreciation & Amortization (CF) of $100000.0 for Q1 2026, little changed year-over-year from $100000.0 in Q1 2025, and little changed quarter-over-quarter from $100000.0 in Q4 2025.
Aytu Biopharma (AYTU) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $100000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) changed 0.0% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $300000.0 (down 93.76% YoY), while the FY2025 annual figure was $200000.0, down 97.58% from the prior year.
- Depreciation & Amortization (CF) held at $100000.0 in Q1 2026 per AYTU's latest filing, from $100000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $2.7 million in Q1 2024 and bottomed at $100000.0 in Q1 2025.
- Historically, Depreciation & Amortization (CF) has averaged $1.6 million across 5 years, with a median of $2.0 million in 2023.
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) increased 22.9% — and 2025, when it slumped 96.29%.
- Aytu Biopharma's Depreciation & Amortization (CF) stood at $2.2 million in 2022, then slipped by 18.81% to $1.8 million in 2023, then declined by 25.24% to $1.3 million in 2024, then plunged by 92.53% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
- Business Quant data shows AYTU's Depreciation & Amortization (CF) at $100000.0 in Q1 2026, $100000.0 in Q4 2025, and $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 1.34 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | 2.69 Mn |
| Mar 31, 2024 | 2.69 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Sep 30, 2023 | 2.23 Mn |